- Home
- / Alder BioPharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Alder BioPharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
| Cost of goods sold | 113.0K | ||||
| General and administrative expense | 12.5M | 16.7M | 26.1M | 38.1M | 47.5M |
| Operating expense total | 45.9M | 86.3M | 158.9M | 291.0M | 286.6M |
| EBIT | 8.8M | (86.3M) | (157.9M) | (291.0M) | (286.6M) |
| Investment income | (185.0K) | (643.0K) | (222.0K) | ||
| Interest income | 44.0K | 702.0K | 2.0M | 2.5M | 8.9M |
| Interest expense | 104.0K | 859.0K | 1.8M | 2.8M | 9.6M |
| Pre tax profit | 8.9M | (85.5M) | (156.1M) | (288.2M) | (296.2M) |
| Net Income | 8.9M | (85.5M) | (156.3M) | (288.9M) | (296.4M) |